MSD's oral cholesterol drug boosted by latest trial results

MSD employs more than 3,000 people in Ireland

MSD Ireland's site in Carlow. MSD employs more than 3,000 people in Cork, Dublin, Carlow, Meath, Tipperary, and Louth. MSD's oral drug met the main goal of reducing bad cholesterol in a late-stage trial, it said on Tuesday. 

MSD's oral drug met the main goal of reducing bad cholesterol in a late-stage trial, it said on Tuesday, marking a second win for the drug since June.

The trial data provides a shot in the arm for the company, which is looking for its next blockbuster candidate as its major revenue driver, Keytruda, is expected to lose patent protection by the end of the decade.